Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once- versus twice-daily insulin detemir in children with type 1 diabetes
IRCT20181106041574N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of insulin detemir in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Tehran University of Medical Sciences. Started Jan 2019; status: completed.
02
Drugs
insulin detemir
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on IRCT20181106041574N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181106041574N1.